Both cIAP1 and cIAP2 regulate TNFα-mediated NF-κB activation
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
The cellular inhibitor of apoptosis 1 and 2 (cIAP1 and cIAP2) proteins have been implicated in the activation of NF-κB by TNFα; however, genetic deletion of either cIAP1 or 2 did not support a physiologically relevant role, perhaps because of functional redundancy. To address this, we used combined genetic and siRNA knockdown approaches and report that cIAP1 and 2 are indeed critical, yet redundant, regulators of NF-κB activation upon TNFα treatment. Whereas NF-κB was properly activated by TNFα in cultured and primary cells deficient in either cIAP1 or 2, removal of both cIAPs severely blunted its activation. After treatment with TNFα, cIAP1 and 2 were rapidly recruited to the TNF receptor 1, along with the adapter protein TNF receptor associated factor 2. Importantly, either cIAP1 or 2 was required for proper TNF receptor 1 signalosome function. In their combined absence, polyubiquitination of receptor interacting protein 1, an upstream event necessary for NF-κB signaling, was attenuated. As a result, phosphorylation of the inhibitor of κB kinase β was diminished, and signal transduction was severely blunted. Consequently, cells missing both cIAP1 and 2 were sensitized to TNFα-mediated apoptosis. Collectively, these data demonstrate that either cIAP1 or 2 is required for proper Rip1 polyubiquitination and NF-κB activation upon TNFα treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Among these, TRAF5 and BIRC3 have functionally redundant counterparts (TRAF2 and BIRC2) (Mahoney et al., 2008; Tada et al., 2001).”
From Optical Pooled Screens in Human Cells (2019) · cites this paper as Mahoney et al., 2008
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, C.-Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., & Baldwin, A. S. (1998) · Science · doi:10.1126/science.281.5383.1680 · Cited by 2,711
Self-citationTumor necrosis factor signaling
Wajant, H., Pfizenmaier, K., & Scheurich, P. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401189 · Cited by 2,359 · cited 1×
“TNF is a pleiotropic cytokine involved in numerous biologic functions, such as the development and proper functioning of the immune system, and tissue regeneration in response to injury (13).”
BackgroundKamata, H., Honda, S.-I., Maeda, S., Chang, L., Hirata, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2004.12.041 · Cited by 1,792
The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases
Roy, N. (1997) · The EMBO Journal · doi:10.1093/emboj/16.23.6914 · Cited by 1,301 · cited 2×
“Biochemical data have indicated that cIAP1 and 2, initially thought to be caspase inhibitors (2), can bind to caspases but do not directly inhibit them (5).”
BackgroundRothe, M., Pan, M.-G., Henzel, W. J., Ayres, T. M., & V. Goeddel, D. (1995) · Cell · doi:10.1016/0092-8674(95)90149-3 · Cited by 1,253 · cited 4×
“Evidence implicating cIAP1 and 2 in TNF -mediated NF- B activation originated from studies demonstrating that they can interact with TRAF2 and can bind to TNF receptors (8, 9).”
BackgroundInfluentialIAP Antagonists Induce Autoubiquitination of c-IAPs, NF-κB Activation, and TNFα-Dependent Apoptosis
Varfolomeev, E., Blankenship, J. W., Wayson, S. M., Fedorova, A. V., Kayagaki, N., Garg, P., Zobel, K., Dynek, J. N., Elliott, L. O., Wallweber, H. J. A., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.030 · Cited by 1,218
IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis
Vince, J. E., Wong, W. W.-L., Khan, N., Feltham, R., Chau, D., Ahmed, A. U., Benetatos, C. A., Chunduru, S. K., Condon, S. M., McKinlay, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.037 · Cited by 1,053 · cited 4×
“Notably, the role of cIAP1 and 2 as negative regulators of stimulus-independent classical and alternative NF- B signaling (11, 12) was uncovered in studies using small-molecule IAP antagonist compounds.”
InfluentialSuppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes
Listen, P., Roy, N., Tamai, K., Lefebvre, C., Baird, S., Cherton-Horvat, G., Farahani, R., McLean, M., lkeda, J.-E., Mackenzie, A., et al. (1996) · Nature · doi:10.1038/379349a0 · Cited by 1,014 · cited 1×
“T cellular inhibitor of apoptosis 1 and 2 (cIAP1 and 2) proteins were identified based on their homology to a family of viral and cellular IAP proteins known to bind to caspases and inhibit their activity (1).”
BackgroundSelf-citationEa, C.-K., Deng, L., Xia, Z.-P., Pineda, G., & Chen, Z. J. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.026 · Cited by 1,000 · cited 3×
“The polyubiquitin chain on Rip1 serves as a docking site for both the TGF- -activated kinase 1 (Tak1) and Tak1 binding proteins 2/3 (Tab2/3) heterocomplex, and the inhibitor of B (I B) kinase (IKK) / / heterocomplex (14, 15).”
BackgroundYang, Y., Fang, S., Jensen, J. P., Weissman, A. M., & Ashwell, J. D. (2000) · Science · doi:10.1126/science.288.5467.874 · Cited by 988 · cited 1×
“In addition, they contain a caspase recruitment domain of unknown function and a RING finger domain that functions as an E3 ubiquitin ligase (4).”
BackgroundIKK/NF- B signaling: balancing life and death - a new approach to cancer therapy
Luo, J.-L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26322 · Cited by 878
Chu, Z.-L., McKinsey, T. A., Liu, L., Gentry, J. J., Malim, M. H., & Ballard, D. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10057 · Cited by 872 · cited 4×
“Subsequent overexpression studies showed that cIAP2 has the capacity to activate NF- B (6) and that a RING-deficient version of cIAP1 can cooperate in the activation of NF- B by TRAF2 (3).”
BackgroundInfluentialNF-κB Signals Induce the Expression of c-FLIP
Micheau, O., Lens, S., Gaide, O., Alevizopoulos, K., & Tschopp, J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.16.5299-5305.2001 · Cited by 813
Chang, L., Kamata, H., Solinas, G., Luo, J.-L., Maeda, S., Venuprasad, K., Liu, Y.-C., & Karin, M. (2006) · Cell · doi:10.1016/j.cell.2006.01.021 · Cited by 706
Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation
Wu, C.-J., Conze, D. B., Li, T., Srinivasula, S. M., & Ashwell, J. D. (2006) · Nature Cell Biology · doi:10.1038/ncb1384 · Cited by 608 · cited 4×
“In support of this, cIAP2 has been shown to directly facilitate K63-linked polyubiquitin chains on Rip1 in vitro (cIAP1 was not examined) (15), and TRAF2 has been shown to enhance the interaction between cIAP1/2 and Rip1 (7).”
InfluentialAutocrine TNFα Signaling Renders Human Cancer Cells Susceptible to Smac-Mimetic-Induced Apoptosis
Petersen, S. L., Wang, L., Yalcin-Chin, A., Li, L., Peyton, M., Minna, J., Harran, P., & Wang, X. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.029 · Cited by 571 · cited 1×
“(12), and several other groups (27, 28), have demonstrated that the ability of Smac-mimetics to kill cancer cells is due to cIAP1 and 2 degradation rather than XIAP antagonism.”
BackgroundShu, H.-B., Takeuchi, M., & Goeddel, D. V. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13973 · Cited by 423 · cited 4×
“It was also reported that cIAP2 was not recruited to TNF-R1 (8), but given the observed functional redundancy between these two proteins in TNF -mediated NF- B signaling, we decided to revisit this question.”
BackgroundInfluentialThe Human Anti-apoptotic Proteins cIAP1 and cIAP2 Bind but Do Not Inhibit Caspases
Eckelman, B. P., & Salvesen, G. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510863200 · Cited by 391 · cited 1×
“Biochemical data have indicated that cIAP1 and 2, initially thought to be caspase inhibitors (2), can bind to caspases but do not directly inhibit them (5).”
BackgroundXIAP Induces NF-κB Activation via the BIR1/TAB1 Interaction and BIR1 Dimerization
Lu, M., Lin, S.-C., Huang, Y., Kang, Y. J., Rich, R., Lo, Y.-C., Myszka, D., Han, J., & Wu, H. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.006 · Cited by 290 · cited 1×
“The related family member Xlinked IAP (XIAP) has also been previously implicated in NF- B signaling in some studies (24), and we therefore evaluated for its role in TNF -mediated NF- B activation.”
BackgroundLee, T. H., Shank, J., Cusson, N., & Kelliher, M. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404206200 · Cited by 255
Gaither, A., Porter, D., Yao, Y., Borawski, J., Yang, G., Donovan, J., Sage, D., Slisz, J., Tran, M., Straub, C., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-5173 · Cited by 224 · cited 1×
“(12), and several other groups (27, 28), have demonstrated that the ability of Smac-mimetics to kill cancer cells is due to cIAP1 and 2 degradation rather than XIAP antagonism.”
BackgroundInhibitor of Apoptosis Protein cIAP2 Is Essential for Lipopolysaccharide-Induced Macrophage Survival
Conte, D., Holcik, M., Lefebvre, C. A., LaCasse, E., Picketts, D. J., Wright, K. E., & Korneluk, R. G. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.2.699-708.2006 · Cited by 191
Self-citationPosttranscriptional Downregulation of c-IAP2 by the Ubiquitin Protein Ligase c-IAP1 In Vivo
Conze, D. B., Albert, L., Ferrick, D. A., Goeddel, D. V., Yeh, W.-C., Mak, T., & Ashwell, J. D. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.8.3348-3356.2005 · Cited by 189 · cited 10×
“Consistent with the earlier report (21), we observed that cIAP1 null MEFs were not sensitive to apoptosis when treated with TNF (Fig.”
BackgroundResultSelf-citationZobel, K., Wang, L., Varfolomeev, E., Franklin, M. C., Elliott, L. O., Wallweber, H. J. A., Okawa, D. C., Flygare, J. A., Vucic, D., Fairbrother, W. J., et al. (2006) · ACS Chemical Biology · doi:10.1021/cb600276q · Cited by 174 · cited 1×
“These compounds were designed to mimic the interaction between XIAP and its antagonist Smac (second mitochondria-derived activator of caspases) and show great promise for the treatment of cancer (26).”
BackgroundSamuel, T., Welsh, K., Lober, T., Togo, S. H., Zapata, J. M., & Reed, J. C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509381200 · Cited by 170 · cited 3×
“Subsequent overexpression studies showed that cIAP2 has the capacity to activate NF- B (6) and that a RING-deficient version of cIAP1 can cooperate in the activation of NF- B by TRAF2 (3).”
BackgroundPark, S.-M., Yoon, J.-B., & Lee, T. H. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.04.021 · Cited by 138 · cited 1×
“In support of this, cIAP2 has been shown to directly facilitate K63-linked polyubiquitin chains on Rip1 in vitro (cIAP1 was not examined) (15), and TRAF2 has been shown to enhance the interaction between cIAP1/2 and Rip1 (7).”
BackgroundBirc2 (cIap1) regulates endothelial cell integrity and blood vessel homeostasis
Santoro, M. M., Samuel, T., Mitchell, T. S., Reed, J. C., & Stainier, D. Y. R. (2007) · Nature Genetics · doi:10.1038/ng.2007.8 · Cited by 137
Holcik, M., Lefebvre, C. A., Hicks, K., & Korneluk, R. G. (2002) · BMC Genomics · doi:10.1186/1471-2164-3-5 · Cited by 45 · cited 1×
“For all experiments, we used our rabbit anti-rat IAP1 (RIAP1) polyclonal antibody to simultaneously detect both cIAP1 and 2 (22), because in our hands it is the only antibody that reliably recognizes cIAP1 and 2 in mouse tissue.”
MethodSelf-citation
Cited by
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study
Yu, H., Lin, L., Zhang, Z., Zhang, H., & Hu, H. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00312-6 · Cited by 2,135
Necroptosis, pyroptosis and apoptosis: an intricate game of cell death
Bertheloot, D., Latz, E., & Franklin, B. S. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00630-3 · Cited by 2,166
Regulated necrosis: the expanding network of non-apoptotic cell death pathways
Berghe, T. V., Linkermann, A., Jouan-Lanhouet, S., Walczak, H., & Vandenabeele, P. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3737 · Cited by 1,735
NF-κB, the first quarter-century: remarkable progress and outstanding questions
Hayden, M. S., & Ghosh, S. (2012) · Genes & Development · doi:10.1101/gad.183434.111 · Cited by 1,693
Mechanisms of Cell Protection by Heme Oxygenase-1
Gozzelino, R., Jeney, V., & Soares, M. P. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105600 · Cited by 1,241
Metadata
- Authors
- Mahoney, D. J., Cheung, H. H., Mrad, R. L., Plenchette, S., Simard, C., Enwere, E., Arora, V., Mak, T. W., Lacasse, E. C., Waring, J., & Korneluk, R. G.
- Affiliations
- Children's Hospital of Eastern Ontario (CA)
- Campbell Family Institute for Breast Cancer Research (CA)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-08-19
- Volume
- 105
- Issue
- 33
- Pages
- 11778-11783
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2575330
- OpenAlex
- W2033914606
- Cited by
- 540
- References
- 28
- Citations by year
- 2026: 19 · 2025: 17 · 2024: 10 · 2023: 25 · 2022: 14 · 2021: 31 · 2020: 22 · 2019: 27 · 2018: 26 · 2017: 27 · 2016: 39 · 2015: 31 · 2014: 44 · 2013: 40 · 2012: 47
- FWCI
- 14.01
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Muscular Dystrophy Association
- Canadian Institutes of Health Research
- Natural Sciences and Engineering Research Council of Canada
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- cIAP1, cIAP2, NF-κB activation, TNF signaling, TNF receptor 1, TRAF2, apoptosis, functional redundancy, signalosome
- MeSH terms
- Animals, Cells, Cultured, Tumor Necrosis Factor-alpha, Signal Transduction, NF-kappa B, Apoptosis, Mice, Knockout, GTPase-Activating Proteins, Myoblasts, Inhibitor of Apoptosis Proteins, Mice, TNF Receptor-Associated Death Domain Protein, Ubiquitination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.